Hadassah

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Friday, Aug 17 2018

Aretha Franklin (Courtesy CSU Archives/Everett Collection)

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET). 

Beloved by countless fans for the transcendent, timeless, and deeply moving quality of her music, Aretha left a legacy that musicians and music lovers will cherish.  Hadassah offers its condolences to Ms. Franklin’s family and relatives on the passing of this American music icon and legend.  The PNET that took Aretha’s life is a rare cancer (~ six percent of all pancreatic tumors), which develops from the abnormal growth of endocrine (hormone-producing) cells in the pancreas.

As Dr. Simona Glasberg, head of the Neuroendocrine Tumor Unit at the Hadassah Medical Organization, explains, "One of the major issues with these tumors is their timely diagnosis, as many times they are missed. Increasing awareness within the medical community and general population of these rare tumors is extremely important, as is the timely referral to a specialized center that is experienced in treating these rare cancers."

Whereas PNETs tend to grow slower than the usual aggressive pancreatic adenocarcinoma, Dr. Glasberg says, “they always have a malignant potential to spread locally or to other organs.  Often, they are diagnosed at an advanced stage of metastatic disease. The symptoms of PNETs are usually related to the tumor-mass growth and spread (e.g., abdominal pain, weight loss, loss of appetite, jaundice, etc.). However, in about 25 percent of cases, these tumors may produce specific hormonal-hypersecretion syndromes, causing diarrhea, severe weakness, sweating, and loss of consciousness. The Neuroendocrine Tumor Unit at Hadassah, with its dedicated multidisciplinary team, is a global leader in NET treatment and research.  Recently,  the European Neuroendocrine Tumor Society (ENETS) certified Hadassah’s unit as the only center of excellence in Israel and the Middle East.  

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Mar 22 2019

On World TB Day, March 24, Hadassah Celebrates Its Success Treating TB

Hadassah has been working on reducing the incidence of tuberculosis for nearly 100 years.

READ MORE ›
alt_text

Thursday, Mar 21 2019

Large Multinational Study Reveals Benefits of Dapagliflozin for Treatment of Diabetes

With 450 million adults worldwide suffering from diabetes today and an increase to more than 640 million expected by 2040, the need for a safe and effective treatment is ever more compelling.

READ MORE ›
alt_text

Tuesday, Mar 19 2019

Hadassah Genetic Research Demystifies Causes of Day Blindness in Families

Fifteen years ago, Prof. Dror Sharon joined the Hadassah Medical Organization’s Center for Retinal and Macular Degeneration to study the genetics of eye disease.

READ MORE ›
alt_text

Wednesday, Mar 13 2019

Saving Lives, Changing Lives at Hadassah-Neurim Youth Aliyah Village

Henrietta Szold was the mother of Youth Aliyah. The first young Jews who came on their own in the mid-1930s were fleeing Hitler. Many never saw their parents again, and they called her Ima. She met their boats, welcomed them, and became their staunch advocate in the no-frills pre-state Israel.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More